Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Healthcare Industry News Why HeartBeam’s 510(k) appeal could reshape cardiac software approval timelines HeartBeam outlines a dual-track regulatory strategy after FDA setback on ECG software. See how it plans to unlock clearance and stay on track for market entry. byPallavi MadhirajuNovember 28, 2025